Open label two treatment half-side comparative study to analyse difference in nasal bioavailability between MP29-02 and fluticasone propionate.

Trial Profile

Open label two treatment half-side comparative study to analyse difference in nasal bioavailability between MP29-02 and fluticasone propionate.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Azelastine/fluticasone-propionate (Primary) ; Fluticasone propionate
  • Indications Allergic rhinitis; Perennial allergic rhinitis; Seasonal allergic rhinitis
  • Focus Pharmacokinetics
  • Acronyms BIODYMF
  • Most Recent Events

    • 26 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top